Physician profile
Andy Liu
NPI 1285082446
$2,563.78
in general payments reported to CMS, 2019-2025
13 companies · $66.86 in 2025
The $66.86 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $327 · 2020: $240 · 2021: $847 · 2022: $374 · 2023: $314 · 2024: $395 · 2025: $66.86.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $775.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $775.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Wilson Cook Medical Incorporated | $725.22 | 2020-2021 | |
| Abbvie INC. | $456.99 | 2021-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $337.67 | 2019-2022 | |
| Phathom Pharmaceuticals, INC. | $259.74 | 2024 | Voquezna |
| Janssen Biotech, INC. | $240.96 | 2023-2024 | Stelara, Tremfya |
| Cook Medical LLC | $157.34 | 2021-2022 | |
| Ironwood Pharmaceuticals, INC | $125.00 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $66.86 | 2025 | Dupixent |
| Genzyme Corporation | $60.20 | 2023 | |
| Novartis Pharmaceuticals Corporation | $46.74 | 2019 | |
| Ardelyx, INC. | $41.04 | 2023 | Ibsrela |
| Pfizer INC. | $32.51 | 2019 | |
| Evoke Pharma, INC. | $13.51 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andy Liu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.